Effect of vitamin D supplementation on antibiotic use: a randomized controlled trial1234
Cited by (0)
- 1
From the Population Health Department, Queensland Institute of Medical Research, Brisbane, Queensland, Australia (BT, DCW, PMW, and REN); the Centre for Research Excellence in Sun and Health, Queensland University of Technology, Kelvin Grove, Queensland, Australia (BT, MGK, DCW, and REN); the School of Population Health, University of Queensland, Brisbane, Queensland, Australia (JCvdP); the Sydney School of Public Health (BKA) and the National Health and Medical Research Council of Australia Clinical Trials Centre, Sydney Medical School (VG), University of Sydney, Camperdown, New South Wales, Australia; Northwest Academic Centre, University of Melbourne, and Western Health, Melbourne, Victoria, Australia (PRE); the School of Population Health, University of Melbourne, Parkville, Victoria, Australia (DRE); the AusSun Research Laboratory, Queensland University of Technology, Kelvin Grove, Queensland, Australia (MGK); and the Menzies Research Institute Tasmania, Hobart, Tasmania, Australia (AV).
- 2
The National Health and Medical Research Council of Australia had no role in the study design, protocol development, trial conduct, data collection or analysis, or interpretation of results.
- 3
Supported by the National Health and Medical Research Council of Australia (NHMRC) (grant 613655 and fellowships to PMW, REN, and AV), the Australian Research Council (a future fellowship to DCW), the Cancer Council Queensland (senior research fellowship to MGK), and the NHMRC Centre for Research Excellence in Sun and Health (postdoctoral research fellowship to BT). The investigational product was supplied free of charge by sanofi-aventis healthcare pty ltd trading as Sanofi Consumer Healthcare.
- 4
Address reprint requests and correspondence to R Neale, Queensland Institute of Medical Research, 300 Herston Road, Herston, Brisbane, Queensland 4006, Australia. E-mail: [email protected].
- 5
Abbreviations used: PBS, Australian Pharmaceutical Benefits Scheme; URTI, upper respiratory tract infection; 25(OH)D, 25-hydroxyvitamin D.